Protein Interactome of Muscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Protein Interactome of Muscle Invasive Bladder Cancer

Published:2015-01-08 Issue:1 Volume:10 Page:e0116404
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bhat Akshay,Heinzel Andreas,Mayer Bernd,Perco Paul,Mühlberger Irmgard,Husi Holger,Merseburger Axel S.,Zoidakis Jerome,Vlahou Antonia,Schanstra Joost P.,Mischak Harald,Jankowski Vera

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference65 articles.

1. Cancer statistics, 2013;R Siegel;CA Cancer J Clin,2013

2. Current therapeutic strategies for invasive and metastatic bladder cancer;P Vishnu;Onco Targets Ther,2011

3. Molecular pathogenesis and diagnostics of bladder cancer;AP Mitra;Annu Rev Pathol,2009

4. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?;A Henning;BJU Int,2013

5. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?;JD Raman;Urol Oncol,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statistical approaches applicable in managing OMICS data: Urinary proteomics as exemplary case;Mass Spectrometry Reviews;2023-05-04

2. Identifying the mRNAs associated with Bladder cancer recurrence;Cancer Biomarkers;2020-08-03

3. Molecular Model for CKD;Integration of Omics Approaches and Systems Biology for Clinical Applications;2018-01-26

4. Mass spectrometric detection combined with bioinformatic analysis identified possible protein markers and key pathways associated with bladder cancer;Gene;2017-08

5. Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention;Oncotarget;2017-04-20